Low Doses of Dexamethasone as monothe... - Advanced Prostate...

Advanced Prostate Cancer

23,807 members29,095 posts

Low Doses of Dexamethasone as monotherapy in mCRPC

MyDad76 profile image
5 Replies

Are there any recent studies that I could show to my dad's doctor?

I found some older ones, but not the most recent.

ncbi.nlm.nih.gov/pmc/articl...

ncbi.nlm.nih.gov/pmc/articl...

researchgate.net/publicatio...

Thank you

Written by
MyDad76 profile image
MyDad76
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Tall_Allen profile image
Tall_Allen

The problem is the cancer becomes resistant quickly at which point they feed tumor growth:

ncbi.nlm.nih.gov/pmc/articl...

MyDad76 profile image
MyDad76 in reply toTall_Allen

Got it, thank you. We have appointment with onco on Monday. My dad has mCRPC, Xtandi is not working anymore. As for scans, his cancer is spread to lymph nodes, but it was only CT scan and bone scan, no PET CT. So based on scan Xofigo is not indicated and Pluvicto is not available in our country. Seems chemo is the only option? He is 81 and I’m not sure he will be willing to travel abroad for Pluvicto or try chemo. He has no comorbidities, but is increasingly more tired and sleeps a lot even during the day (not sure if it is from Xtandi or disease itself).

GP24 profile image
GP24

Dexamethasone reduces the testosterone produced by the adrenal cortex and limits the inflammation caused by the tumor. I would add 1.0 mg Dexa to the current treatment and monitor if and how long it works using the PSA value. It cannot be used as a monotherapy but you can combine it with Eligard.

MyDad76 profile image
MyDad76 in reply toGP24

Thank you, will def. bring it to the table on Monday, when we have appointment with onco. It seems we have nothing / very little to lose at this stage.

FCoffey profile image
FCoffey

Take a look at

Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate A Randomized, Open-Label Phase 2 Study

ncbi.nlm.nih.gov/pmc/articl...

Median radiographic progression-free survival was

18.5 months with prednisone, 5 mg, twice daily,

15.3 months with prednisone, 5 mg, once daily,

12.8 months with prednisone, 2.5mg, twice daily,

26.6months with dexamethasone 0.5 mg daily.

I discussed this article with my oncologist 4 years ago (almost to the day) and we agreed to substitute dexamethasone for prednisone while taking abiraterone. So far so good. Last MRI reported no progression.

Not what you're looking for?

You may also like...

Enzalutamide may have synergistic effect on Lu-177 Pluvicto treatment

found these recent published studies that indicate short-term use (2 weeks) of enzalutamide prior...
Kayakbob profile image

Food supplements I hope will help

I had: PSA 30, Gleason 10, PCa Stage 4 localized to pelvic region. Treated with IMRT radiation +...
Brad70 profile image

Confused about how all the different PCa drugs work?

This recent article (Oct 2023) has a nice high level diagram that organizes the more common...

ADT enhances the immune system

Recent data are showing that the covid-19 death rate among Italian men is much higher than among...
Tall_Allen profile image

Another chummy connection to parasites and prostate cancer?

After diving into therapies for Chagas(I apparently have it ...waiting for second confirmation...
sammamish profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.